Jaguar Health Calls Special Meeting; No Quorum, No Votes Taken

What Happened

• Jaguar Health, Inc. announced on September 4, 2026 that its special meeting of stockholders did not have a sufficient number of shares of voting Common Stock or Series Q Perpetual Preferred Stock present or represented by proxy to constitute a quorum. As a result, no votes were taken on the proposals in the Company’s definitive proxy statement (filed August 3, 2026), and no business was conducted. The Company stated it will not adjourn or postpone this Special Meeting and the meeting will not be reconvened.

Key Details

• Date of event: September 4, 2026 (Special Meeting called to order but lacked quorum).
• Securities involved: Voting Common Stock (par value $0.0001) and Series Q Perpetual Preferred Stock (par value $0.0001).
• Outcome: No votes taken, no business conducted, and the Company will not adjourn/postpone or reconvene this meeting.
• Next steps: Jaguar Health will evaluate whether to call a new special meeting in the future to consider the same or similar proposals.

Why It Matters

• For investors, the immediate effect is that any proposals submitted for shareholder approval were not decided and remain unresolved. That can delay corporate actions tied to those proposals (e.g., governance changes, financings or other matters disclosed in the proxy).
• The company’s statement that it may evaluate calling a new special meeting is a forward-looking indication only; investors should review Jaguar Health’s SEC filings (including its 2025 Form 10-K risk factors) for risks and additional context before making decisions.